A decade after sparking the Seaport’s boom, Vertex is considering leaving Fan Pier
Boston's most valuable biotech? Vertex. “As Vertex scales for future ... it would leave a huge chunk of empty lab and office ...
The Business Journals1mon
Five things: Vertex's new drug, a new downtown hotel, Takeda's new CEO and Punxsutawney Phil
Good morning, Boston. Here are the five things you need to know in local business news to start your Friday, including Vertex's new drug, a new downtown hotel, Takeda's new CEO, and the ...
The Boston Globe11d
Unleased lab space. Plunging valuations. Layoffs. In Massachusetts, the biotech slump is taking its toll.
Despite some notable successes, including US approval in January of a nonopioid painkiller by Boston biotech Vertex, there are few signs the industry — responsible for more than 115,000 ...
The Boston Globe18d
Vertex’s non-opioid pain drug gets some UnitedHealth coverage
Like other drug companies, Boston-based Vertex has a program that helps patients with insurance reduce their out-of-pocket costs for treatments. A UnitedHealth representative had no immediate comment.